Revcovi
Southern Health and Social Care TrustcontractFind a Tender ↗Ref ocds-h6vhtk-0592c8Procurement Act 2023pending
Estimated value
—
Awarded value
£4.0m
Awarded 02 Sept 2025
Suppliers
1
Lots
1
1 awarded
Published
03 Sept 2025
Description
Procurement of Revcovi, an approved enzyme replacement therapy (ERT) indicated for the treatment of adenosine deaminase severe combined immune deficiency.
Scope
- Reference
- ocds-h6vhtk-0592c8
- Commercial tool
- Standalone contract
Submission & procedure
- Procedure
- Direct award
Award details
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
£4.0m
Award date
02 Sept 2025
Contract start
14 Sept 2025
Contract end
14 Sept 2028
Awarded to
CL
CH 02140985
Awarded suppliers· 1 supplier
Awarded 02 Sept 2025 · Contract period 14 Sept 2025 — 14 Sept 2028
Award value
£4.0m
Other contracts from Southern Health and Social Care Trust
Full notice and award history for this contracting authority is on the buyer profile.
Other contracts awarded to CHIESI LIMITED· 10
Cross-buyer view of this supplier's public-sector wins.
| Title | Type | Value | Published |
|---|---|---|---|
| Generic, Branded Generic & Proprietary Medicinal Products - Group 18 | contract | — | 03 Jul 2026 |
| NP36126 Antibiotic & Genito Urinary Medicines | contract | — | 25 May 2026 |
| NHS National Generic Pharmaceuticals - Wave 15c | contract | — | 26 Feb 2026 |
| NHS National Generic Pharmaceuticals - Wave 15c | contract | — | 14 Jan 2026 |
| Generic, Branded Generic & Proprietary Medicinal Products - Group 17 | contract | — | 12 Jan 2026 |
| NP40925 Analgesics, Anaesthetics, Musculoskeletal & Joint Disease Medicines | contract | — | 06 Jan 2026 |
| NHS National Framework for Generics Housekeeping | contract | — | 22 Dec 2025 |
| NP49425 Generic and Biosimilar Transition Medicines | contract | — | 19 Dec 2025 |
| NHS National Framework for Generics Housekeeping | contract | — | 11 Nov 2025 |
| NP41125 Immunosuppressant Medicines | contract | — | 29 Aug 2025 |